Wirtek

Dagens aktienyheder med Alk-Abello, Rovsing, ExpreS2ion Biotechnologies, Trifork og Wirtek

In connection with the new strategy and Q3 2025 results, we have updated our investment case one-pager. In addition to highlighting key investment reasons and risks, we have also updated the case with peer group valuation perspectives based on selected Danish IT companies and Nordic IT consultancy companies.

Today, Wirtek’s CEO Michael Aaen and CFO Mads Greiffenberg presented the company’s Q3 2025 results and outlined the key building blocks of its new strategic plan, which as a first step aims to return the company to a growth trajectory in 2026. The presentation was followed by a Q&A session.

Wirtek is expected to release its Q3 2025 interim report on November 11, 2025. The management will present the results at a virtual live event with a Q&A session on the same day at 14:00 CET. In addition to the financial results, the presentation will include an update on Wirtek’s recent business developments and provide insights into the current market environment.

Dagens aktienyheder med Sampo plc, Columbus, ExpreS2ion Biotechnologies og Wirtek A/S

Mød ledelsen i Wirtek og stil spørgsmål til dagens investorpræsentation

I dagens Morgenbørs ser vi ind i et stort hop op i de amerikanske futures på en mulig amerikansk genåbning. Herhjemme er der blandt andet fokus på Novo Nordisk og Genmab.

Dagens aktienyheder med Gubra, Columbus og Wirtek

Today Wirtek has unveiled a new corporate strategy laying the foundation to return to growth in 2026. The elements of the strategy appear well aligned with what we see from other IT consultancies and the general direction of the market:

Dagens aktienyheder med TORM, Columbus, BioPorto A/S, WindowMaster, Wirtek A/S, GomSpace, MPC Energy Solutions og GrønlandsBANKEN

Dagens aktienyheder med DS NORDEN, Curasight og Wirtek A/S

Dagens aktienyheder med Wirtek A/S

Last week, Wirtek reported its H1 2025 report. The macroeconomic uncertainty has affected Wirtek’s results, as revenue declined by -11% in the first half of the year. It should however be noted, that a large part of the negative growth is due to the completion of a major Danish client engagement. To align with the headwinds, Wirtek has implemented cost-saving initiatives that have ensured a return to positive EBITDA in Q2 2025, which is one quarter earlier than previously targeted. We have updated our investment case one-pager following the recent results and news.